Menu Back to DIA-2013-49th-Annual-Meeting-Advancing-Therapeutic-Innovation-and-Regulatory-Science

Program Committee

  • Sandra A. Milligan, JD, MD
    Sandra A. Milligan, JD, MD Senior Vice President, Head of Regulatory Affairs and Safety Merck Research Laboratories, United States
  • J. Lynn  Bass, PharmD, RPh
    J. Lynn Bass, PharmD, RPh Director, Medical Affairs Jazz Pharmaceuticals, United States
  • Annetta C. Beauregard, MBA, MS
    Annetta C. Beauregard, MBA, MS Vice President, US Regulatory Strategy EMD Serono, Inc., United States
  • Larry A. Blankstein, PhD
    Larry A. Blankstein, PhD Consultant, Clinical Development Blankstein Consulting Group, United States
  • Linda F. Bowen, MS, RAC
    Linda F. Bowen, MS, RAC Head, US Regulatory Policy and Intelligence Sanofi, United States
  • Joan  Buenconsejo
    Joan Buenconsejo Statistics Team Leader, Inflammation, Neuroscience & Respiratory TA, B&I Science AstraZeneca Pharmaceuticals LP, United States
  • Jonca C. Bull, MD
    Jonca C. Bull, MD Assistant Commissioner for Minority Health, Office of the Commissioner FDA, United States
  • Thomas M. Casola, MBA
    Thomas M. Casola, MBA Vice President, Global Regulatory Affairs, Advertising, Promotion, and Labeling Shire Specialty Pharmaceuticals, United States
  • Nancie E. Celini, DrPH
    Nancie E. Celini, DrPH Chief Health Technology Advisor and Educator CAB Inc., United States
  • Leah  Christl, PhD
    Leah Christl, PhD Associate Director for Therapeutic Biologics, OND, CDER FDA, United States
  • Anne B. Cropp, PharmD
    Anne B. Cropp, PharmD Vice President Pfizer Inc, United States
  • Nancy A. Dreyer, PhD, MPH, FISPE
    Nancy A. Dreyer, PhD, MPH, FISPE Global Chief of Scientific Affairs, Real-World and Late Phase Research Quintiles Real-World & Late Phase Research, United States
  • Charles  Drucker, MBA
    Charles Drucker, MBA Director of Operations and Project Management Quest Diagnostics, United States
  • Lauren  Edelstein Henry
    Lauren Edelstein Henry Senior Principal Operational Specialist Janssen Pharmaceutical Companies of Johnson & Johnson, United States
  • Kathleen  Findlen
    Kathleen Findlen Head of Clinical Operations and Project Management Piramal Life Sciences, United States
  • Ron D. Fitzmartin, PhD, MBA
    Ron D. Fitzmartin, PhD, MBA Senior Advisor, Data Standards Program, Office of Strategic Programs, CDER FDA, United States
  • Michael  Folkendt, MS
    Michael Folkendt, MS Associate Director, Office of Programs and Regulatory Operations, OPQ, CDER FDA, United States
  • Stacey M. Fung, PharmD
    Stacey M. Fung, PharmD Associate Director, Medical Communications Genentech, A Member of the Roche Group, United States
  • Jonathan  Haddad, MPH, MT
    Jonathan Haddad, MPH, MT Director, Clinical Statistics GlaxoSmithKline, United States
  • Martin  Harvey Allchurch, LLM
    Martin Harvey Allchurch, LLM Principal International Affairs Officer European Medicines Agency, European Union , United Kingdom
  • Alan M. Hochberg
    Alan M. Hochberg Senior Process Development Leader F. Hoffmann-La Roche Ltd., Switzerland
  • Mark J. Hope
    Mark J. Hope Vice President, Global Head of Regulatory Affairs UCB SA, Switzerland
  • Christopher J. Hoyle, MBA
    Christopher J. Hoyle, MBA Executive Director Elite Research Network, United States
  • David  Jacobson-Kram, PhD
    David Jacobson-Kram, PhD Associate Director for Pharmacology and Toxicology, Office of New Drugs, CDER FDA, United States
  • Nirdosh  Jagota, PhD
    Nirdosh Jagota, PhD Vice President and Head Regulatory CMC Merck, United States
  • Janet  Jenkins-Showalter
    Janet Jenkins-Showalter Head, US Regulatory Policy Genentech, A Member of the Roche Group, United States
  • Agnes V. Klein, DrPH, MD
    Agnes V. Klein, DrPH, MD Director, Evaluation of Radiopharmaceuticals and Biotherapeutic Products Health Canada, Canada
  • Tatsuo  Kurokawa, PhD
    Tatsuo Kurokawa, PhD Professor, Div. of Drug Development and Regulatory Sciences, Faculty of Pharmacy Keio University, Japan
  • Sheila  Lapping
    Sheila Lapping Senior Director, Outsourcing Management Takeda Global Research & Development Center Inc., United States
  • Jeffrey  Litwin
    Jeffrey Litwin President Litwin Consulting, United States
  • Barry  Mangum, PharmD
    Barry Mangum, PharmD Chief Executive Officer Paidion Research, Inc., United States
  • JeanMarie  Markham
    JeanMarie Markham Chief Executive Officer Clinlogix LLC, United States
  • Christopher M. Marrone, PharmD
    Christopher M. Marrone, PharmD Outcomes Liaison Eli Lilly and Company, United States
  • Munish  Mehra, PhD
    Munish Mehra, PhD Managing Director Quantum Biopharma, United States
  • Jon  Meyer, MBA, MSc
    Jon Meyer, MBA, MSc Co-Founder and Managing Member Life Science Strategy Group, LLC, United States
  • C. Latham  Mitchell, MD
    C. Latham Mitchell, MD Erudita Biotechnical LLC, United States
  • Christine M. V. Moore, PhD
    Christine M. V. Moore, PhD Acting Director, Office of Process and Facilities, OPQ, CDER FDA, United States
  • Patrick C. O'Brien, JD, PharmD
    Patrick C. O'Brien, JD, PharmD General Counsel Arrowhead Research Corporation, United States
  • Shaghig  Palanjian
    Shaghig Palanjian Head of Research and Development Quality Assurance and Compliance Shire Pharmaceuticals, United States
  • James L. Parmentier, PhD
    James L. Parmentier, PhD Professor Rutgers School of Health Related Professions, United States
  • Pradip  Paul, MD, MS
    Pradip Paul, MD, MS Consultant Strategic Pharmacovigilance and Risk Management, United States
  • Kirsten H. Paulson, MS, RAC
    Kirsten H. Paulson, MS, RAC Senior Director, Global CMC Medical Devices Pfizer Inc, United States
  • Kim M. Quaintance
    Kim M. Quaintance Head, US Regulatory Policy Bayer HealthCare Pharmaceuticals, United States
  • Badri  Rengarajan, DrMed
    Badri Rengarajan, DrMed Study Physician, Medical Affairs Actelion, United States
  • Margaret S. Richards, PhD, MPH
    Margaret S. Richards, PhD, MPH Executive Director, Epidemiology and Health Outcomes PPD, United States
  • Janet "Lucy"  Rose, MBA
    Janet "Lucy" Rose, MBA President Lucy Rose and Associates, LLC, United States
  • Abdul J. Sankoh, PhD, MA, MS
    Abdul J. Sankoh, PhD, MA, MS Vice President, Biostatistics and Clinical Informatics Synageva Biopharma, United States
  • Gregg  Schneider
    Gregg Schneider Director, R&D Financial Management Otsuka Pharmaceutical Development & Commercialization, Inc., United States
  • Suzanne  Sensabaugh, MBA, MS
    Suzanne Sensabaugh, MBA, MS President and Principal Consultant HartmannWillner LLC, United States
  • Leigh  Shultz, PhD, PMP
    Leigh Shultz, PhD, PMP Executive Director, Global Project Management Merck & Co., Inc., United States
  • Ling  Su, PhD
    Ling Su, PhD Strategic Advisor, Life Sciences Sidley Austin LLP, China
  • Patrick J. Thomas, MS
    Patrick J. Thomas, MS Director, US Group Lead - Adult & Travellers Vaccines GlaxoSmithKline, United States
  • Carolynn  Thomas-Jones
    Carolynn Thomas-Jones The Ohio State University, United States
  • Toshiyoshi  Tominaga
    Toshiyoshi Tominaga Associate Executive Director for International Programs Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Jurgen  Venitz, MD, PhD
    Jurgen Venitz, MD, PhD Professor, Pharmaceutics Virginia Commonwealth University, United States
  • Keith W. Wenzel
    Keith W. Wenzel Senior Director Perceptive Partner Program, United States
  • Albert I. Wertheimer, PharmD, PhD, MBA
    Albert I. Wertheimer, PharmD, PhD, MBA Professor of Pharmacy Administration, School of Pharmacy Temple University, United States
  • Linda Fossati Wood, MPH, RN
    Linda Fossati Wood, MPH, RN President MedWrite, Inc., United States
Load More